Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study to Test Safety and Dose of Proglumide as an Anti-fibrotic Agent in Non-alcoholic Steatohepatitis (NASH)

NCT04152473 is registered in ClinicalTrials.gov with Georgetown University as lead sponsor.

NCT NCT04152473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04152473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study to Test Safety and Dose of Proglumide as an Anti-fibrotic Agent in Non-alcoholic Steatohepatitis (NASH)
Lead sponsor
Georgetown University
Phase
Phase 1
Overall status
Completed
Start date
December 13, 2019
Completion date
September 9, 2022
Enrollment
18 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

nonalcoholic steatohepatitis